Clinical Trial Update: Remifentanil in Extracorporeal Shock Wave Lithotripsy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating remifentanil during extracorporeal shock wave lithotripsy for nephrolithiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Remifentanil (Ultiva) (remifentanil)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Kidney Calculi | Phase 4 | Status: COMPLETED